Molecular profiling of allergen-antibody IgE might decide about the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites

CONCLUSIONS: HDM AIT could be helpful for patients with moderate-to-severe AD and sensitised to HDM as an add-on therapy. Various HDM molecules may affect the effectiveness of the expected AIT.PMID:37692262 | PMC:PMC10485758 | DOI:10.5114/ada.2023.129456
Source: Advances in Dermatology and Allergology - Category: Dermatology Authors: Source Type: research